Long‐term antidyskinetic efficacy of amantadine in Parkinson's disease
Long‐term antidyskinetic efficacy of amantadine in Parkinson's disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Long‐term antidyskinetic efficacy of amantadine in Parkinson's disease have?
Long‐term antidyskinetic efficacy of amantadine in Parkinson's disease has 186 citations in the OpenAlex counts ScholarIQ stores.
When was Long‐term antidyskinetic efficacy of amantadine in Parkinson's disease published?
Long‐term antidyskinetic efficacy of amantadine in Parkinson's disease has 2010 year in the ScholarIQ index.
What is the open-access status of Long‐term antidyskinetic efficacy of amantadine in Parkinson's disease?
Long‐term antidyskinetic efficacy of amantadine in Parkinson's disease has closed oa status in the ScholarIQ index.
What is the DOI of Long‐term antidyskinetic efficacy of amantadine in Parkinson's disease?
The DOI for Long‐term antidyskinetic efficacy of amantadine in Parkinson's disease is on the source record.
What is the PMID of Long‐term antidyskinetic efficacy of amantadine in Parkinson's disease?
The PMID for Long‐term antidyskinetic efficacy of amantadine in Parkinson's disease is on the source record.
What is the OpenAlex record for Long‐term antidyskinetic efficacy of amantadine in Parkinson's disease?
The OpenAlex for Long‐term antidyskinetic efficacy of amantadine in Parkinson's disease is on the source record.